Stay updated on Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.

Latest updates to the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page
- Check3 days agoChange DetectedA general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page content, and the site revision number changes from v3.7.1 to v3.7.2. The study page itself continues to show a 403 error.SummaryDifference1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check31 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the full study record, with a simple header and a Home link. This replaces the previously visible study details and navigation, effectively locking access to the trial information on this page.SummaryDifference20%

- Check38 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 on the page, signaling a new version of the page content or metadata. This appears to be a maintenance update and does not alter the study information shown.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.6.6 updated from v3.6.5, representing a small maintenance update to the page's metadata for the study record.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a maintenance update to the study record page. No substantive study content or participant information changes are evident in the provided context.SummaryDifference0.0%

Stay in the know with updates to Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.